» Articles » PMID: 29796340

The Independent Specialty Medical Advocate Model of Patient Navigation and Intermediate Health Outcomes in Newly Diagnosed Cancer Patients

Overview
Specialty Oncology
Date 2018 May 26
PMID 29796340
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Navigation programs are generally characterized as providing patient-centered support and guidance intended to help patients and family members overcome barriers such as timely diagnosis resolution, patient satisfaction, coping with primary and adjuvant treatment, management of side effects, and patient engagement in the healthcare process. The aim of this study was to examine the associations between the Independent Specialty Medical Advocate (ISMA) model of patient navigation and intermediate patient health outcomes for newly diagnosed cancer patients.

Methods: A pre-post intervention study was conducted in 26 newly diagnosed cancer patients recruited from a national partnership between the LIVE Cancer Navigation Service Program and the NavigateCancer Foundation between April 2013 and December 2015. Participants received a 1-hour initial telephone consultation, and then a navigation care plan was developed for the 6-week study period. A paired test was conducted to assess changes in intermediate health outcomes at baseline and 6 weeks after study intervention.

Results: The majority of study participants were males (62%), married (50%), and Caucasian (69%). Overall, there was a statistically significant reduction in anxiety at 6 weeks postintervention (mean, 2.48; SD, 0.62; <.05) compared with baseline (mean, 2.92; SD, 0.82) and in depression at 6 weeks postintervention (mean, 2.00; SD, 0.81; <.05) compared with baseline (mean, 2.45; SD, 0.19).

Conclusion: The ISMA model of patient navigation appears to be associated with significant reduction in anxiety and depression. Further studies are needed to evaluate the ISMA model of patient navigation on long-term patient outcomes.

Citing Articles

Examining ACCURE's Nurse Navigation Through an Antiracist Lens: Transparency and Accountability in Cancer Care.

Griesemer I, Lightfoot A, Eng E, Bosire C, Guerrab F, Kotey A Health Promot Pract. 2022; 24(3):415-425.

PMID: 36582178 PMC: 11384289. DOI: 10.1177/15248399221136534.


Evaluating the implementation and impact of navigator-supported remote symptom monitoring and management: a protocol for a hybrid type 2 clinical trial.

Rocque G, Dionne-Odom J, Stover A, Daniel C, Azuero A, Huang C BMC Health Serv Res. 2022; 22(1):538.

PMID: 35459238 PMC: 9027833. DOI: 10.1186/s12913-022-07914-6.


Patient Navigation in Cancer: The Business Case to Support Clinical Needs.

Kline R, Rocque G, Rohan E, Blackley K, Cantril C, Pratt-Chapman M J Oncol Pract. 2019; 15(11):585-590.

PMID: 31509483 PMC: 8790714. DOI: 10.1200/JOP.19.00230.

References
1.
Post D, McAlearney A, Young G, Krok-Schoen J, Plascak J, Paskett E . Effects of Patient Navigation on Patient Satisfaction Outcomes. J Cancer Educ. 2014; 30(4):728-35. PMC: 7217374. DOI: 10.1007/s13187-014-0772-1. View

2.
Wolf M, Chang C, Davis T, Makoul G . Development and validation of the Communication and Attitudinal Self-Efficacy scale for cancer (CASE-cancer). Patient Educ Couns. 2005; 57(3):333-41. DOI: 10.1016/j.pec.2004.09.005. View

3.
Smith M, Wallston K, Smith C . The development and validation of the Perceived Health Competence Scale. Health Educ Res. 1995; 10(1):51-64. DOI: 10.1093/her/10.1.51. View

4.
Jean-Pierre P, Fiscella K, Freund K, Clark J, Darnell J, Holden A . Structural and reliability analysis of a patient satisfaction with cancer-related care measure: a multisite patient navigation research program study. Cancer. 2010; 117(4):854-61. PMC: 3017733. DOI: 10.1002/cncr.25501. View

5.
Freeman H . The history, principles, and future of patient navigation: commentary. Semin Oncol Nurs. 2013; 29(2):72-5. DOI: 10.1016/j.soncn.2013.02.002. View